MCDB is proud to announce the establishment of an Emphasis in Pharmacology and Biotechnology within the M.A. degree. The proposal for the new degree was approved last week by the Graduate Council and Letters and Science Executive Committee. The new interdisciplinary Master's Emphasis is designed to take advantage of the many interdisciplinary opportunities in the fields of pharmacology and biotechnology on the UCSB campus. Students have the option of enrolling in a wide variety of courses offered through three UCSB departments, MCDB, Chemistry and Biochemistry, and Psychology.
Research from the laboratory of Thomas Weimbs in MCDB points to potential new drug therapies for patients with polycystic kidney disease. The findings, implicating the transcription factor STAT3 as a promising drug target, are published in this week's issue of the Proceedings of the National Academy of Sciences.
Studies of the small sea squirt may ultimately help solve the problem of rejection of organ and bone marrow transplants in humans, according to recent work from Professor De Tomaso's laboratory in MCDB.
Gary Wilcox is a trustee of The UC Santa Barbara Foundation and currently chairman of the board and CEO of a start-up antiviral drug discovery company, Cocrystal Discovery, Inc. Previously, he was executive vice president of ICOS Corporation in Bothell, Washington, and earlier he co-founded International Genetic Engineering, serving as its chairman, president, and CEO until its merger with XOMA Corporation in 1989. From 1974 until 1984, Wilcox was a professor of microbiology and a member of the Molecular Biology Institute at UCLA.
One of our MCDB faculty members is one of three scientists who have been named the recipients of the 11th annual Albany Medical Center Prize in Medicine and Biomedical Research. The pioneering work of these three scientists in isolating human stem cells holds great promise for the future of medicine. Prize recipient James A.
Capps, the U.S. Representative for California's 23rd congressional district, toured several research laboratories in MCDB, and talked to graduate students and postdoctoral fellows at the bench. She led a round-table discussion with professors, students and Dean Wiltzius to discuss the impact that the recently proposed drastic cuts in federal research funding would have on research at UCSB, education and the nation's future competitiveness.
"Filling the Blank," a documentary by Cable News Network featuring the research of MCDB professor Kenneth S. Kosik, was broadcast Saturday, Jan. 29.
Greider, a professor of molecular biology and genetics at Johns Hopkins University, visited UCSB for three days to talk to MCDB faculty, deliver two lectures in the Frontiers of Cancer Research Series, and was honored as the first UCSB alumna to win a Nobel Prize. Greider graduated from UCSB in 1983 and conducted research as an undergraduate the laboratory of Leslie Wilson, an MCDB faculty member.
An interdisciplinary team of researchers mainly at UC Santa Barbara, including Ph.D. student Rebecca Werlin in the laboratory of Professor Eduardo Orias in MCDB, has produced a groundbreaking study of how nanoparticles are able to biomagnify in a simple microbial food chain. This study was published in the journal Nature Nanotechnology.
Remarkable progress in understanding how stem cell biology works has been reported by a team of scientists led by MCDB professor Ken Kosik. Their research using microRNA profiling revealed two distinct p53-related human pluripotent stem cell states and has been published in the journal Cell Stem Cell.